Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ginko International is a leading manufacturer and distributor of contact lenses and lens care products, primarily serving the Greater China market. The company operates under well-known brands such as Hydron and Miluoke, offering a wide range of products including soft contact lenses, specialty lenses for myopia control, and lens cleaning solutions. Headquartered in Taiwan with significant manufacturing facilities in China, Ginko maintains a dominant market share in the region's vision care sector. The company's vertically integrated business model covers research and development, manufacturing, and an extensive distribution network. In 2022, Ginko was acquired and taken private by a consortium led by Baring Private Equity Asia in a deal valued at approximately $1 billion. This acquisition highlights the company's strategic importance in the growing global ophthalmology and medical device landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ginko International.